DUBLIN--(BUSINESS WIRE)--The "Global Travel Vaccines Market Analysis 2017 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. The report analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
Key Topics Covered
1 Introduction
2 Executive Summary
3 Market Analysis
4 Porter's Five Forces Analysis
5 Travel Vaccines Market by Product Type
6 Travel Vaccines Market by Type of Uses
7 Travel Vaccines Market by Application
8 Geographical Segmentation
9 Vendor Landscaping
10 Company Profiles
- Sanofi S.A.
- Pfizer Inc
- GlaxoSmithKline
- Merck & Co. Inc.
- AstraZeneca
- Abbott
- Janssen Pharmaceuticals
- LG Life Sciences
- Mitsubishi Tanabe Pharma
- Roche
- Shenzhen Kangtai Biological Products
- Takeda Pharmaceutical
- Lupin
- Valeant Pharmaceuticals
- GlycoVaxyn
- Hualan Biological Engineering
- Serum Institute of India
- Indian Immunologicals
- Beijing Minhai Biotechnology
For more information about this report visit https://www.researchandmarkets.com/research/jv2gss/global_travel?w=4
